OADS
OADS is a Chloride channel antiporter (ClC-ec1) inhibitor (IC50: 29 μM) . OADS specifically inhibits the ClC-ec1 antiporter but not the ClC-1 channel. OADS can be used for research of osteoporosis and neurodegenerative and cardiovascular diseases[1].
Product Specifications
CAS Number
5970-15-0
UNSPSC
12352005
Target
Chloride Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Field of Research
Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/oads.html
Purity
98.25
Smiles
O=S(C1=CC(NC(CCCCCCC)=O)=CC=C1/C=C/C2=CC=C(NC(CCCCCCC)=O)C=C2S(=O)(O)=O)(O)=O
Molecular Formula
C30H42N2O8S2
Molecular Weight
622.79
References & Citations
[1]Howery AE, et al. A designed inhibitor of a CLC antiporter blocks function through a unique binding mode. Chem Biol. 2012 Nov 21;19 (11) :1460-70.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 4
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Protochlamydia amoebophila Phosphoglucosamine mutase (glmM)
Recombinant Protochlamydia amoebophila Phosphoglucosamine mutase (glmM)
Recombinant Protochlamydia amoebophila Phosphoglucosamine mutase (glmM)
Recombinant Protochlamydia amoebophila Phosphoglucosamine mutase (glmM)
Recombinant Protochlamydia amoebophila Phosphoglucosamine mutase (glmM)